Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement
Периоперационное ведение взрослых пациентов, принимающих агонисты рецепторов глюкагоноподобного пептида-1, агонисты рецепторов глюкозозависимого инсулинотропного полипептида и ингибиторы натрий-глюкозного котранспортёра 2-го типа: мультидисциплинарное консенсусное заключение
2025-01-09
SCID: 54.1/yhk9jsex
Discuss with AI
GIP receptor agonistsGLP-1 receptor agonistsSGLT2 inhibitorsperi-operative managementpulmonary aspiration
Figures from the paper
Abstract (AI)
INTRODUCTION: Glucagon-like peptide-1 receptor agonists, dual glucose-dependent insulinotropic peptide receptor agonists and sodium-glucose cotransporter-2 inhibitors are used increasingly in patients receiving peri-operative care. These drugs may be associated with risks of peri-operative pulmonary aspiration or euglycaemic ketoacidosis. We produced a consensus statement for the peri-operative management of adults taking these drugs. METHODS: This multidisciplinary consensus statement included surgeons, anaesthetists, physicians, pharmacists and people with lived experience relevant to these guidelines. Following the directed literature review, a three-round modified Delphi process was conducted to generate and ratify recommendations. RESULTS: Patients taking glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic peptide receptor agonists should: continue these drugs before surgery; have full risk assessment and stratification; and receive peri-operative techniques that may mitigate risk of pulmonary aspiration before, during and after sedation or general anaesthesia. Patients taking sodium-glucose cotransporter-2 inhibitors should omit them the day before and the day of a procedure. All patients should have risks and mitigation strategies discussed with a shared decision-making approach. DISCUSSION: Until more evidence becomes available, this pragmatic, multidisciplinary consensus statement aims to support shared decision-making and improve safety for patients taking glucagon-like peptide-1 receptor agonists, dual glucose-dependent insulinotropic peptide receptor agonists and sodium-glucose cotransporter-2 inhibitors during the peri-operative period.
Key Findings
1
A multidisciplinary modified Delphi process produced consensus recommendations for peri-operative management of adults taking GLP-1, GIP, and SGLT2 drugs.
2
For GLP-1 and dual GIP agonist users, peri-operative techniques should be considered to mitigate pulmonary aspiration risk around sedation or general anaesthesia.
3
Management decisions should incorporate shared discussions of risks and mitigation strategies, acknowledging limited available evidence.
4
Patients taking GLP-1 receptor agonists or dual GIP receptor agonists should continue treatment before surgery after individualized risk assessment and stratification.
5
Patients taking SGLT2 inhibitors should omit these medications on the day before and the day of a procedure to reduce peri-operative risk of euglycaemic ketoacidosis.
Research Object
Adults taking glucagon-like peptide-1 receptor agonists, dual glucose-dependent insulinotropic peptide receptor agonists, or sodium-glucose cotransporter-2 inhibitors during the peri-operative period
Research Subject
Peri-operative medication management, risk assessment, and mitigation of pulmonary aspiration and euglycaemic ketoacidosis
Publication Details
Publication Date
2025-01-09
Journal
Publisher
ISSN
Cited by
177
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai6
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes2016
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes2016
Tirzepatide Once Weekly for the Treatment of Obesity2022
Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia2024
Anesthesia Considerations for a Patient on Semaglutide and Delayed Gastric Emptying2023
Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss2024
Cited by6
Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia2025
Unmasking Aspiration Risks: A Propensity‐Matched Odyssey of GLP‐1 Receptor Agonists and Colonoscopy2025
Preoperative management algorithm for endoscopic or surgical interventions in patients receiving incretin mimetics2026
Perioperative medicine: what do you need to know about new hypoglycemic drugs?2026
Perioperative risks of glucagon-like peptide-1 receptor agonists and their implications in airway management using supraglottic airway devices2026
GLP-1 Receptor Agonists: Clinical Considerations and Risk Management for Patients Undergoing Ophthalmic Surgery2026